|
|
||||||||
Physiological Reviews, Vol. 80, No. 1, January 2000, pp. 315-360
Copyright ©2000 by the American Physiological Society
Department of Pharmacology and Neuroscience, University of Dundee, Dundee, Scotland; and Cerebrovascular and Neuroscience Research Institute, Brigham and Women's Hospital, Boston, Massachusetts
I. INTRODUCTION
II. MITOCHONDRIAL PROTON CIRCUIT
A. Isolated Mitochondria
B. Proton Circuit and the Intact Cell
C. Use of Ionophores to Probe Mitochondrial Function in Intact Cells
D. Respiratory Chain Inhibition in Intact Cells
E. Mitochondrial ATP Synthase Inhibition in Intact Cells
III. MITOCHONDRIAL MEMBRANE POTENTIAL, pH GRADIENT, AND PROTON-MOTIVE FORCE
A. Isolated Mitochondria
B. In Situm and
pH
IV. MITOCHONDRIAL CALCIUM TRANSPORT
A. Isolated Mitochondria
B. Ca2+ Transport by In Situ Mitochondria
V. REACTIVE OXYGEN SPECIES AND MITOCHONDRIA
A. ROS Generation by Isolated Mitochondria
B. Mitochondria and the Cellular Generation of ROS
C. Oxidative Damage to Isolated Mitochondria
VI. MITOCHONDRIA AND NEURONAL GLUTAMATE EXCITOTOXICITY
A. Pathways of Ischemic Glutamate Release
B. Role of the NMDA Receptor
C. Bioenergetic Consequences of Acute Glutamate Exposure
D.m and Glutamate Excitotoxicity
E. Mitochondrial Ca2+ Sequestration and Glutamate Exposure
F. Mitochondrial ROS During Glutamate Exposure
VII. MITOCHONDRIA AND GLUTAMATE-INDUCED DELAYED CALCIUM DEREGULATION
A. DCD and ATP Synthesis
B. DCD and the MPT
C. Mitochondrial Depolarization Protects Neurons Against DCD
D. Superoxide, Oxidative Stress, and DCD
E. Role of NO· in DCD
F. Is DCD Caused by Oxidative Damage to the Plasma Membrane Ca2+-ATPase?
G. At What Stage in DCD Do the Mitochondria Undergo Bioenergetic Failure?
H. Synergy Between Bioenergetic Restriction and Excitotoxicity
VIII. MITOCHONDRIA AND APOPTOSIS
A. Biochemistry of Apoptosis
B. Cytochrome c Release From Isolated Mitochondria
C. Release of Cytochrome c and Apoptosis-Inducing Factor by Mitochondria In Situ
D. Role of the Permeability Transition in the Release of Cytochrome c
IX. MITOCHONDRIAL FUNCTION DURING APOPTOSIS IN NEURAL CELL LINES AND NEURONAL CULTURES
A. Trophic Factor Withdrawal
B. Bioenergetic Limitation
C. Staurosporine-Induced Apoptosis
D. Ceramide-Induced Apoptosis
E. Glutamate-Induced Apoptosis
X. CONCLUSIONS
| |
ABSTRACT |
|---|
|
|
|---|
Nicholls, David G. and
Samantha L. Budd.
Mitochondria and Neuronal Survival. Physiol. Rev. 80: 315-360, 2000.
Mitochondria play a central role in the survival and death of
neurons. The detailed bioenergetic mechanisms by which isolated mitochondria generate ATP, sequester Ca2+, generate
reactive oxygen species, and undergo Ca2+-dependent
permeabilization of their inner membrane are currently being applied to
the function of mitochondria in situ within neurons under physiological
and pathophysiological conditions. Here we review the functional
bioenergetics of isolated mitochondria, with emphasis on the
chemiosmotic proton circuit and the application (and occasional
misapplication) of these principles to intact neurons. Mitochondria
play an integral role in both necrotic and apoptotic neuronal cell
death, and the bioenergetic principles underlying current studies are reviewed.
| |
I. INTRODUCTION |
|---|
|
|
|---|
The first great wave of mitochondrial research stretched from the 1940s, with the pioneering work of Lehninger, Chance, Slater, Ernster and others through the "chemiosmotic revolution" initiated by Peter Mitchell, to the early 1980s. During this period, the basic mitochondrial functions were identified and characterized with increasing precision, and the organelle emerged as a beautifully self-regulating machine for generating ATP (see Ref. 416 for review). In view of the central role played by mitochondria in cellular metabolism, it was assumed that the organelle was highly reliable and associated with few disease states. Indeed, almost the only mitochondrial dysfunction known was the extremely rare Luft's disease (344) in which "loose coupling" was detected in mitochondria from a hypermetabolic patient. Mitochondrial research therefore became increasingly focused on the elucidation of the molecular machinery of the proton pumps. However, in recent years, there has been a resurgence of interest in the functional aspects of mitochondria with the realization that, far from being perfect machines, mitochondria are fragile structures operating near their physicochemical limits, whose dysfunction appears to underlie a host of degenerative disease states in the brain. Furthermore, it has recently been discovered that mitochondria have an additional role, participating directly in the signaling pathways that culminate in apoptosis.
A complex and disparate variety of factors can influence cell survival, but in this review we focus on bioenergetic aspects, and in particular how mitochondrial function controls cell survival. Initial sections review the bioenergetics of mitochondria both in isolation and within the healthy cell. This is followed by discussion of the application of these studies to pathophysiological and degenerative conditions. To keep this review within manageable bounds, the emphasis is on neurons and neuronal mitochondria, but general principles obtained with other cell types are also discussed. Related topics including mitochondrial mutation (105, 187, 199, 334, 505, 506, 510, 626) and mitochondria and aging (126, 187) have been recently reviewed and so are not covered here.
| |
II. MITOCHONDRIAL PROTON CIRCUIT |
|---|
|
|
|---|
Mitochondria exert a multifactorial influence on cell function. In
addition to ATP synthesis they can accumulate Ca2+ whenever
the local cytoplasmic free Ca2+ concentration
([Ca2+]c) rises above a critical "set
point" (11, 265, 410); under some conditions this can
result in a nonspecific permeabilization of the inner membrane, the
"mitochondrial permeability transition" (MPT) (for review, see
Refs. 42, 634). In addition, changes in mitochondrial Ca2+
can regulate tricarboxylic acid cycle enzymes (367). The
mitochondrial respiratory chain is also the major site for the
generation of superoxide radicals (O2
·) (for
review, see Refs. 534, 575). Each of these parameters is influenced by,
and can in turn influence, the mitochondrial membrane potential
(
m). Through the ATP/ADP pool, mitochondria can
influence glycolysis, the activity of Ca2+- and
Na+-K+-ATPases at the plasma membrane and
consequently the activity of Na+-coupled plasma membrane transporters.
Because the manipulation of a single mitochondrial parameter may affect many cellular functions, experiments must be designed with care. It follows that an understanding of the basic bioenergetics of isolated mitochondria is essential to be able to monitor and manipulate mitochondrial function in the much more complex environment of the intact cell.
A. Isolated Mitochondria
Electrons from NADH enter complex I of the respiratory chain (Fig.
1) at a redox potential of
300 mV and
emerge to reduce a membrane-associated ubiquinol/ubiquinone
(UQH2/UQ) pool close to 0 mV. Electrons from
flavin-linked dehydrogenases (such as succinate dehydrogenase) have
an insufficiently negative redox potential to enter complex I and
instead reduce the UQH2/UQ pool via complex II. Ubiquinol
transfers electrons to complex III, which in turn reduces cytochrome
c (at a redox potential of approximately +250 mV).
Cytochrome c then reduces the terminal acceptor complex IV
(also called cytochrome-c oxidase) which then transfers four electrons to molecular oxygen. Complexes I, III, and IV function as
proton pumps, acting in series with respect to the electron flux and in
parallel with respect to the proton circuit (Fig. 1). The fall in redox
potential of the electrons passing through these complexes is used to
generate a proton electrochemical potential gradient,
µH+, usually expressed in electrical potential units as the proton-motive force (
p)
|
(1) |
|

m is the mitochondrial membrane potential
(a positive value corresponding to a negative matrix),
pH is the pH
gradient across the inner membrane (a positive value indicating an
acidic matrix), and R, T and F refer
to the gas constant, the absolute temperature, and the Faraday
constant, respectively. Under most conditions, 
m is
the dominant component of
p, accounting for 150-180 mV of the total
proton-motive force of 200-220 mV (387, 408). A
fourth component of the inner mitochondrial membrane, the
energy-linked transhydrogenase (237), utilizes
p to
maintain a high level of reduction of the matrix NADP(H) pool by
driving the following reaction to the right
|
(2) |
|
The ATP synthase is the dominant pathway for the reentry of protons
into the mitochondrial matrix. The proton-motive force forces this
ATP-hydrolyzing proton pump to run in reverse and synthesize ATP.
ATP is not a "high-energy compound"; rather, the mitochondrion
holds the ATP synthesis reaction (ADP + Pi = ATP) up to 10 orders of magnitude away from equilibrium (408,
482). The Gibbs free energy (
G) for a reaction in a cell is
simply a measure of this displacement from equilibrium; at 37°C, this means that the
G for ATP synthesis in the cytoplasm is close to +60
kJ/mol.
An instructive analogy is to compare the proton circuit to an
equivalent electrical circuit (Fig. 1), where
p is the potential term, the effective proton conductance of the inner membrane
corresponds to the conductance (reciprocal resistance) of a component,
and the consequent proton current flowing round the circuit is governed by Ohm's law (for review, see Ref. 416). Because the proton circuit is
completed by the reentry of protons through the ATP synthase, which in
turn is tightly coupled to ATP synthesis, it follows that the proton
current responds automatically to ATP demand. Tight coupling between
electron flux and proton pumping in each respiratory chain complex
means that electron flux (and hence respiration) is in turn controlled
by ATP demand, the phenomenon of respiratory control. The fixed
H+/2e
stoichiometry of the
individual respiratory chain complexes means that the proton current
can be calculated from the respiratory rate multiplied by the
H+/2e
(406). Because
the potential term
p can be calculated (see sect.
IIIA), application of Ohm's law allows the
effective proton conductance of the membrane to be derived under a wide
range of experimental conditions (406, 409).
Isolated mitochondria respire in state 4 (the state when there is no
extramitochondrial ATP hydrolysis and hence no proton reentry via the
ATP synthase) due to a constitutive proton leak across the inner
membrane. This leak is highly potential dependent ("nonohmic"),
being maximal in state 4 and dropping to almost zero in state 3 (the
state when extramitochondrial ATP turnover and hence proton reentry via
the ATP synthase is maximal) (409, 425, 480). The proton
leak limits the respiratory control ratio (state 3 divided by state 4 respiration) to between 5 and 10 depending on the substrate (408,
409, 480). Substrates such as succinate that feed electrons into
complex II generate a significantly higher
p than complex I
substrates and in consequence display a higher nonohmic proton leak
(408). The nonohmic leak plays a major role in controlling
basal metabolic rate (480) and in addition may limit the
production of potentially dangerous reactive oxygen species (ROS)
(534). The respiratory chain complexes are efficient transducers of redox potential into
p; indeed, complexes I and III
(but not IV) operate close to thermodynamic equilibrium. This means
that changes in
p affect the redox state of components within these
complexes, and this in turn has important consequences for the cell's
susceptibility to oxidative stress (see sect.
VIID).
As with an electrical circuit,
p drops slightly when the proton
current is increased (409). The only communication between the respiratory chain and the ATP synthase is via the proton circuit, and it is the difference between the "static head"
p, at which there would be no proton pumping, and the actual
p that is
responsible for controlling respiration. With isolated mitochondria,
p in state 3 is 10-15% lower than in state 4 (387,
406). Although this difference is small, it can be further
reduced in many cells under conditions of high metabolic activity by a
Ca2+-mediated activation of key dehydrogenases (for review,
see Refs. 211, 367). This generates an enhanced reduction of NADH,
increasing the static head
p to compensate for the greater
disequilibrium required to drive the more rapid ATP generation
(479).
Protonophores can be used to titrate the proton conductance of the
membrane, and in excess can virtually collapse
p, leading to
maximal, uncontrolled respiration (387, 409). The ATP
synthase will reverse in the presence of a protonophore, hydrolyzing
extramitochondrial ATP; as will be discussed in the cellular context,
protonophores are a highly effective means of depleting
extramitochondrial ATP.
Mitochondria possess an inherent monovalent cation/H+
exchanger that prevents Na+ or K+ accumulation
in the matrix in response to the high 
m (386, 407). The ionophore nigericin (465) is a
K+/H+-selective exchanger that in high
K+ media (equivalent to a physiological cytoplasm) can
decrease
pH and cause a compensatory increase in

m. The K+ uniport ionophore valinomycin
collapses 
m in high K+ media and causes
massive swelling.
B. Proton Circuit and the Intact Cell
Mitochondrial and cellular bioenergetics are intimately
interlinked (Fig. 2). In neurons, the
dominant mitochondrial substrate is pyruvate derived from glycolysis
(230). Mitochondrial respiration is controlled by ATP
turnover ("respiratory control"), which in neuronal cells is
primarily a consequence of the ATP demand for plasma membrane ion
pumping. The rate of glycolysis is controlled by mitochondrially
generated ATP via the Pasteur effect (445); in neuronal
preparations, inhibition of oxidative phosphorylation can lead to a
10-fold enhancement in the rate of glucose utilization (159, 160,
283). Importantly, a collapse in
p will lead not only to a
cessation of mitochondrial ATP synthesis, but to a rapid hydrolysis of
cytoplasmic ATP as the ATP synthase reverses in an attempt to restore
p. This can lead to profound depletion of ATP. Finally, to compound
the complexity, the design of experiments to investigate mitochondrial
function in intact cells must overcome the relative inaccessibility of
the in situ mitochondria and the presence of other compartments and
membrane systems.
|
The isolated nerve terminal (synaptosome) preparation retains an intact plasma membrane, cytoplasm, mitochondria, associated metabolic pathways, and all the machinery for the uptake, storage, and release of neurotransmitter (for reviews, see Refs. 160, 372, 411, 606). Although the synaptosomal preparation is enriched in presynaptic nerve terminals and not representative of an intact neuron, it represents one of the simplest preparations in which to model neuronal mitochondrial/cellular interactions. However, it must be kept in mind that synaptic and nonsynaptic mitochondria differ somewhat in their respiratory capacities; notably, synaptic mitochondria have a lower threshold before inhibition of complex I restricts state 3 respiration (115).
Respiration, and thus the proton current flowing across the inner membrane of the in situ mitochondria, is one of the few bioenergetic parameters that is not more difficult to determine in synaptosomes than in isolated mitochondria. The respiratory stimulation produced by protonophores indicates that the in situ mitochondria within rat cortical synaptosomes have 500% spare respiratory capacity (160, 517). The Na+-K+-ATPase is the major ATP-requiring process, thus its inhibition with ouabain substantially inhibits basal respiration (160, 272, 517), while addition of veratridine to prevent voltage-activated Na+ channels from inactivating results in a 300% increase in respiration driving the rapid cycling of Na+ and K+ across the plasma membrane (156, 160, 272, 517, 585, 588). The residual respiration in the presence of oligomycin (which inhibits the ATP synthase) can be used to quantify the proton leakage across the mitochondrial membrane and can detect classic "uncoupling" of the in situ mitochondria.
Accurate estimation of the
G for the cytoplasmic adenine nucleotide
pool is difficult. The
G is a function of free
[ATP]/([ADP][Pi]) in the cytoplasm rather than the
ATP level per se. Whole cell ATP/ADP greater than ~5 generally
reflect a healthy synaptosomal preparation (73, 160),
whereas ratios approaching 15:1 are characteristic of primary cultures
of neurons and glia (526). However, it must be kept in
mind that these values are a combination of the mitochondrial and
cytoplasmic pools.
C. Use of Ionophores to Probe Mitochondrial Function in Intact Cells
The mitochondrial membrane potential 
m (or the
proton-motive force
p) is the central parameter controlling
three fundamental cellular processes: ATP synthesis, mitochondrial
Ca2+ sequestration, and the generation of ROS. Conversely,

m is itself controlled by substrate availability, ATP
demand, respiratory chain capacity, mitochondrial proton conductance,
and mitochondrial Ca2+ sequestration. In this and
subsequent sections we review experimental protocols that allow many of
these parameters to be independently modulated.
Because ionophores induce ion permeabilities in lipid bilayers, they display virtually no membrane selectivity (465). Ionophores may induce relatively nonselective cation channels in membranes (e.g., gramicidin) or may be selective mobile carriers catalyzing the electrogenic uniport of a single ion [e.g., protonophores (H+) or valinomycin (K+ or Rb+)] or the electroneutral exchange of two species [e.g., K+/H+ (nigericin) or Ca2+/2H+ (ionomycin or A-23187)].
Protonophores have been widely employed in the cellular context to
depolarize mitochondria (e.g., Refs. 118, 173, 292, 293, 392, 448, 449,
539, 549, 550, 559, 566, 598). However, protonophore addition to an
intact cell has multiple consequences; the ionophore will acidify the
cytoplasm by equilibrating protons across the plasma membrane
(569, 597) and deplete synaptic vesicles of their
contents, particularly amino acids, by collapsing the transvesicular
p (80, 419, 599). At the mitochondrion, the protonophore will collapse 
m (inhibiting
mitochondrial Ca2+ accumulation and releasing any
accumulated Ca2+), reverse the ATP synthase (leading to a
rapid hydrolysis of cytoplasmic ATP, Ref. 73), inhibit the generation
of O2
·, and perhaps induce the MPT. Finally, the
decreased cytoplasmic ATP may prevent Na+ and
Ca2+ extrusion from the cell and lead to a subsequent
failure of glycolysis if ATP levels are below those needed by
hexokinase. For a cell to survive in the presence of protonophore,
the capacity of glycolytic ATP generation must therefore exceed that
required by the cell plus that consumed by the reversed ATP synthase;
this only seems to be the case for cells with a limited population of mitochondria.
Great care must be taken in the use of other ionophores in the cellular
context. The K+ uniport ionophore valinomycin cannot be
used with intact cells unless it is the intention to swell and
depolarize the in situ mitochondria (184, 489). Although
nigericin (465) collapses intracellular
pH gradients
between compartments containing an equal concentration of
K+ and consequently allows mitochondria to hyperpolarize
(604), the K+ > Na+
selectivity for nigericin is only 25-45 (461), allowing
high concentrations of the ionophore (>1 µM) to depolarize the
plasma membrane, dissipate the Na+ and K+
gradients across the plasma membrane, and short-circuit the
Na+-K+-ATPase (158, 160).
D. Respiratory Chain Inhibition in Intact Cells
A variety of inhibitors exist selective for each respiratory chain complex (Fig. 1). Because respiratory chain inhibitors target specific mitochondrial components, they are free of the inherent membrane nonselectivity characteristic of ionophores, although some complex IV inhibitors have additional, nonmitochondrial, sites of action. Inhibition of any one complex will block electron transfer through the entire respiratory chain. Complex III inhibition (by, for example, antimycin A or myxathiazol) or complex IV inhibition (by, for example, azide, cyanide, carbon monoxide, or NO·) will inhibit electron flow to the terminal oxidase. Even though two separate complexes (I and II) reduce complex III, inhibition of either will affect respiration in an intact cell, since the supply of succinate for complex II is dependent on preceding NAD+-linked dehydrogenases in the tricarboxylic acid cycle, whereas inhibition of succinate dehydrogenase or complex II will also block the cycle, limiting the generation of NADH.
Because redox components upstream of the site of inhibition will become
reduced, whereas those downstream will be oxidized, the inhibitors can
be used to control the redox state of specific regions of the
respiratory chain. This is of particular interest in complex III, where
myxathiazol inhibits upstream of the ubisemiquinone site, which is the
major source of mitochondrial O2
·, whereas
antimycin A inhibits downstream, and, by increasing the occupancy of
this site, increases O2
· generation
(576). The immediate bioenergetic consequences of respiratory chain inhibition are largely independent of the site of
inhibition. Because respiratory chain-linked proton extrusion ceases,
p decays, stopping ATP synthesis and allowing the ATP synthase to reverse. The resultant hydrolysis of cytoplasmic ATP occurs
more slowly than in the presence of protonophore (see sect. IIC) since the inner membrane retains its low
permeability to protons. This slow hydrolysis of ATP is sufficient to
maintain 
m at levels only slightly lower than in the
absence of inhibitor (517).
In synaptosomes, rotenone inhibition of complex I (517) or 3-nitropropionic acid (3-NPA) inhibition of complex II (157) leads to a fall in ATP and phosphocreatine levels. The ability of a cell to maintain function in the presence of respiratory chain inhibitors appears in the short term to be governed by the ability of glycolysis to supply sufficient ATP for cell metabolism as well as for this ATP synthase reversal. As any spare ATP-generating capacity of the cell is depleted, the susceptibility of cells to factors that increase ATP demand is enhanced proportionately.
E. Mitochondrial ATP Synthase Inhibition in Intact Cells
Oligomycin is a selective inhibitor of the Fo proton
well of the mitochondrial ATP synthase (270), although
high concentrations may also inhibit the plasma membrane
Na+-K+-ATPase (169). Because both
synthesis and hydrolysis of ATP by the mitochondrion are prevented, the
organelle will not consume ATP regardless of subsequent bioenergetic
manipulations. Oligomycin thus allows the key mitochondrial function of
ATP synthesis to be selectively inhibited, and the cell will survive as
long as the glycolytic capacity of the cell is sufficient to maintain ATP in the absence of oxidative phosphorylation. Mitochondrial membrane
potential is not only maintained in the presence of oligomycin but is
increased by a few millivolts (46, 143, 489, 517) due to
the inhibition of proton reentry via the ATP synthase. As a
consequence, 
m-dependent functions including
mitochondrial Ca2+ transport and the generation of
O2
· will be maintained, or even increased as a
consequence of the slight mitochondrial hyperpolarization. Most
importantly, the further addition of a protonophore or respiratory
chain inhibitor will not a priori cause a depletion of ATP, allowing

m to be manipulated without the complications of
bioenergetic failure (73, 74, 141, 188, 325).
The ability of cells to maintain bioenergetic homeostasis in the presence of oligomycin will depend on their glycolytic capacity. Cerebellar granule cells in culture have a high glycolytic capacity and can be maintained for several hours in the presence of the inhibitor (73, 74). However, cultured hippocampal neurons in some studies (63, 139, 508, 539) but not others (62) show signs of energetic limitation in the presence of the inhibitor.
| |
III. MITOCHONDRIAL MEMBRANE POTENTIAL, pH GRADIENT, AND PROTON-MOTIVE FORCE |
|---|
|
|
|---|
A. Isolated Mitochondria
The membrane potential 
m is the
mitochondrial parameter most frequently estimated in intact cells. We
first review the methodologies that have been employed with isolated
mitochondria, while bearing in mind that their extrapolation to intact
cells may not always be valid. The two components of
p are
determined separately. The 
m value is estimated from
the gradient of a permeable cation across the inner membrane.
Initially, K+ or Rb+ was employed in a low
K+ medium in the presence of valinomycin (387,
408). Subsequently, membrane-permeant phosphonium cations,
triphenylmethylphosphonium (TPMP+), or
tetraphenylphosphonium (TPP+), were used, either as
isotopes (543) or in combination with a selective
phosphonium electrode (273).
To calculate 
m from the phosphonium ion accumulation,
it is necessary to determine the matrix volume (as
sucrose-impermeable, H2O-permeable space, Ref. 417) and
the activity coefficient of the cation within the matrix by
establishing a calibration from diffusion potentials generated by
valinomycin in the presence of defined extramitochondrial
K+ concentrations (609). The
pH is
determined from the equilibrium distribution of weak acids such as
acetic acid that are membrane permeant in the protonated but not
anionic forms (387, 408). Finally,
p is calculated from
these experimentally determined values (Eq. 1).
Cationic membrane-permeant fluorescent probes have been much
employed to monitor 
m. Their use with isolated
mitochondria is dependent on the quenching of their fluorescence due to
stacking of the probe molecules at the high concentrations achieved
within the polarized mitochondrial matrix (339). Under
these conditions, the total fluorescence of a suspension of
mitochondria will decrease if the organelles hyperpolarize and more
probe is sequestered within the matrix. Because this technique depends
largely on an empirical aggregation or stacking of the probe, results
are highly dependent on dye concentration, and results are generally
calibrated by reference to K+ diffusion potentials obtained
in the presence of valinomycin. Furthermore, great care must be taken
to ensure that mitochondrial function is not compromised by the
accumulated probe; for example, the cationic cyanine dye
3,3'-dihexyloxacarbocyanine iodide
[DiOC6(3)] has been reported to be a
particularly potent inhibitor of mitochondrial complex I (50%
inhibition by <10 nM dye equilibrated with cells; Refs. 124, 488,
489).
In the presence of physiological concentrations of phosphate and
Mg2+, isolated mitochondria from liver, heart, brown fat,
or brain (387, 408, 543) maintain a total
p of some 220 mV in state 4, of which the membrane potential 
m
comprises 150-180 mV with a
pH of
0.5 to
1 pH unit contributing
the remaining 30-60 mV (Eq. 1). In the presence of excess
phosphate,
pH remains small and 
m generally
shadows
p. This may justify the general failure to consider the
pH component in discussions of in situ mitochondrial energization,
although as discussed in section IVA there are
conditions associated with Ca2+ accumulation where this
relationship falls down.
B. In Situ 
m and
pH
The determination of both components of
p for mitochondria in
situ is complex. In addition to the need to determine matrix volume and
probe binding, the presence of the intervening plasma membrane, with
its own membrane potential and pH gradient has to be considered
(128, 517). Hoek et al. (236) first
quantified
p for in situ hepatocyte mitochondria;

m was determined from the Nernstian distribution of
[3H]TPMP+ between the cytoplasm and matrix,
after correcting for the plasma membrane potential
(
p), while
pH was measured by weak acid distribution, again controlling for the gradient across the plasma membrane. A value for
p of >200 mV was consistent with values obtained with isolated mitochondria. Subsequently, the phosphonium cations have been used as isotopes or with a TPP+-selective
electrode (273) to quantify the 
m
component (typically some 150 mV) for mitochondria within isolated
nerve terminals (6, 517) and a variety of cells, including
sea urchin sperm (504), basophilic leukemia cells
(494), lymphocytes (59), thymocytes
(60), hepatocytes (206, 425, 426), and
perfused rat hearts (596).
The distribution of phosphonium cations such as TPMP+ and
TPP+ is responsive to both 
m and

p
|
(3) |
|
(4) |
|
(5) |

p is negative, 
m is positive). The
logarithmic nature of the above equations requires comment,
particularly in the context of the fluorescent probes discussed below.
A signal that is proportional to the concentration of the probe in the
mitochondrion does not translate into a linear function of membrane
potential. Thus, for example, a report of a 30% decrease in signal
(e.g., Ref. 78) does not translate into a 30% decrease in

m (e.g., from 180 to 125 mV) but rather a much more
modest decrease from 180 to 170 mV. Attempts to quantify

m from the extent of phosphonium cation binding after
washing to remove free cation (82) are of course invalid.
The extension of the use of cationic fluorescent membrane potential
indicators from isolated mitochondria to cells requires considerable
care to avoid misleading artifacts. The probes are accumulated into
intracellular mitochondria in the same way as the phosphonium cations:
first across the plasma membrane in response to 
p and
then from cytoplasm to matrix in response to 
m.
Although confocal microscopy can resolve the fluorescence of single
intracellular mitochondria loaded with a membrane potential probe
(340), direct determination of the Nernstian gradient
between matrix and cytoplasm by confocal microscopy is extremely
difficult because of the small size of the mitochondria, the enormous
dynamic range required to quantify the 300-fold gradient corresponding
to a 150-mV potential, and the need to work at low concentrations of
probe that do not produce quenching (or inhibition) within the matrix.
Although it is virtually impossible to exclude extramitochondrial
volume from the optical slice, Loew and co-workers
(167) have devised compensating deconvolution algorithms
for tetramethylrhodamine ester fluorescence from single in situ
mitochondria. In addition, Ubl et al. (583) have evaluated
the possibility of comparing the fluorescence intensity of
mitochondria-poor regions (such as the nucleus in a thin optical
section) with that of the mitochondria-rich cytoplasm and have
concluded that with appropriate calibration (valinomycin-induced
K+ diffusion potentials in permeabilized cells) that an
estimate of 
m up to 140 mV may be obtained with an
accuracy of ±20 mV.
Plasma membrane and mitochondrial membrane potentials are determined from the free rather than bound concentrations of probe; thus the fixable cationic probe chloromethyl-tetramethyl-rosamine methyl ester (CMTMR; Mitotracker orange) (54, 593) poses serious limitations. The principle is that the cationic probe accumulates in the matrix and then reacts via its chloromethyl group with thiol groups, allowing the cells to be washed, fixed, and monitored. Unfortunately, it is not clear that the amount of chemically reacted CMTR is directly proportional to the free matrix concentration and whether the thiol groups remain in excess or become saturated.
At single-cell resolution, two general protocols have been adopted.
In the first, the putative change in 
m is established before addition of the probe. Total cell fluorescence, i.e., the sum of
nonmitochondrial and mitochondrial contributions, is monitored, a
decrease relative to controls being ascribed to a mitochondrial depolarization. Unfortunately, cells are frequently washed in the
absence of probe before or during measurement, thus disturbing the
Nernst distribution across the plasma membrane. The fluorescence will
then depend on the rate at which the membrane-permeant probe effluxes from the cell. In addition, most of these studies fail to take
account of the extent of fluorescence quenching of the highly
concentrated probe within the mitochondrial matrix (155).
Matrix quenching is deliberately exploited in the second protocol,
which is suitable in principle for the continuous monitoring of

m. If trans-plasma membrane equilibration
of the probe is slow in relation to that across the mitochondrial inner
membrane, a decrease in 
m will be reported as an
increased whole cell fluorescence as more probe moves from the
relatively quenched environment of the matrix to the cytoplasm
(339). Conversely, a mitochondrial hyperpolarization will
cause a decreased whole cell fluorescence. Commonly employed dyes
include rhodamine-123 (47, 73, 74, 141, 155, 257, 267, 286, 290,
463), DiOC6(3) (84, 348, 349,
488, 489, 495, 623), and the tetramethylrhodamine methyl or
ethyl esters [TMRM or TMRE (148, 340, 423,
508)]. The cationic
5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazol-carbocyanine iodide (JC-1) (477) has been used in a different mode
(107, 240, 476, 604). Above a critical concentration in
the matrix, the probe forms red-emitting (590 nm) J-aggregates
and below this concentration green-emitting (527 nm) monomers.
Redistribution of probe between the matrix and cytoplasm in response to
a decrease in 
m will of course increase the
concentration in the latter compartment. However, because the probe is
permeant across the plasma membrane (the pathway for its initial
loading), it follows that the resultant increase in cytoplasmic
concentration should lead to a secondary efflux of probe from the
cytoplasm to restore the plasma membrane Nernst equilibrium with a
consequent decrease in signal. The actual shape of this biphasic
fluorescent response to mitochondrial depolarization will depend on the
relative permeability of the mitochondrial and plasma membranes to the probe and the geometry of the cell. The high surface-to-volume ratio
possessed by small cells and cell processes such as neurites means that
the secondary decrease in fluorescence follows rapidly upon the initial
increase (415), whereas in large cell bodies the secondary
efflux can be slower.
Because the cytoplasmic concentration of these probes at equilibrium is
sensitive to 
p, the probes are also responsive to plasma membrane depolarization, as shown for the phosphonium cations (Eq. 2). This consideration is of particular relevance under
conditions where 
p changes, for example, KCl
depolarization of neurons or
N-methyl-D-aspartate (NMDA) receptor activation.
The actual behavior of individual probes is largely empirical; thus the
slow decrease in TMRM fluorescence seen when cultured neurons are
challenged with glutamate (508) primarily reflects the
decrease in 
p accompanying receptor activation
(415).
The fluorescent signal from some probes [e.g., rhodamine-123
(141) and JC-1 (495)] has been reported to
be insensitive to changes in plasma membrane potential, although Davis
et al. (119) observe a strong 
p
dependency of rhodamine-123 fluorescence in MCF-7 cells. Furthermore,
changes induced by high KCl (141) or glutamate in the
absence of Ca2+ (604) fail to affect the
red-to-green emission ratio of JC-1. This could either imply that
redistribution across the plasma membrane of these probes is so slow
that loss of probe from the cells is unimportant or that the signal
results from predominantly bound rather than free probe, which would
imply that the probes are not responding in the Nernstian mode required
for interpretation of the fluorescence changes. A recent paper by
Rottenberg and Wu (489) analyzed in great detail the use
of DiOC3(6) for the determination of

m in lymphocytes by flow cytometry, a technique which
has been widely employed to estimate changes in 
m
(84, 348, 349, 439, 623). Rottenberg and Wu
(489) conclude that the concentrations at which the dye is
normally employed (40-100 nM) result in a 90% inhibition of cell
respiration (hence lowering 
m), quenching of the
signal within the matrix, and a response selective for

p rather than 
m (489).
It is important to remain cautious in the detailed interpretation of
the fluorescence changes of 
m monitoring probes and to seek some independent confirmation of the bioenergetic status of the
in situ mitochondria. In particular, reliable application of a
particular probe to the measurement of 
m in one cell
type should not be taken to mean that it can be used in the same way with other cells. Calibration with defined effectors of

m and 
p should be performed with
each new cell type.
Very recently, a promising technique for monitoring the pH of
intracellular compartments has been described, based on the pH-sensitive fluorescence of targeted Aequoria victoria
green-fluorescent protein mutants (296, 336).
Mitochondria in situ within HeLa cells displayed a
pH of
0.5 units
(336) consistent with values obtained with isolated mitochondria.
| |
IV. MITOCHONDRIAL CALCIUM TRANSPORT |
|---|
|
|
|---|
A. Isolated Mitochondria
The inner mitochondrial membrane possesses a uniporter, which remains to be identified at a molecular level, able to transport Ca2+, but not Mg2+, into the matrix (for review, see Refs. 203, 211, 412). The high mitochondrial membrane potential dictates that thermodynamic equilibrium would be attained if the free matrix Ca2+ rose to a value 105-106 higher than in the extramitochondrial medium. This potentially lethal accumulation does not however occur, due to the presence in the inner membrane of a separate efflux pathway which exchanges Ca2+ for protons (e.g., liver mitochondria) or for Na+ (e.g., heart, brain, and brown fat mitochondria) (114). In the latter tissues, a mitochondrial Na+/H+ transporter is present, and the overall ion flux under conditions of constant mitochondrial Ca2+ loading consists of sequential Ca2+, Na+, and H+ cycling (113, 114), the last driven by the respiratory chain (Fig. 2).
In the presence of physiological concentrations of phosphate, an osmotically inactive Ca2+-phosphate complex forms in the matrix at a critical Ca2+ loading (318), and the activity of the efflux pathway is found to be invariant above this value (632). The complex is not a hydroxyapetite-like precipitate, since depolarization of the inner membrane leads to a rapid independent efflux of Ca2+ via the reversed uniporter and phosphate on its transporter. The factors that prevent precipitation of calcium phosphate in the matrix are unclear, although phosphocitrate has been proposed as an antinucleation agent preventing crystallization (564). When there is sufficient Ca2+ and phosphate to form this complex, mitochondria behave as perfect buffers of extramitochondrial Ca2+ ([Ca2+]o), accumulating the cation whenever its concentration rises above the set point at which uptake and efflux balance and releasing Ca2+ below this value (40, 410). The set point can vary between 0.3 and 1 µM (58, 323, 410, 418), with the actual value depending on the kinetics of the two pathways. Thus the set point can be shifted to a higher [Ca2+]o by activating the efflux pathway or inhibiting the uniporter. This can be observed with isolated brain mitochondria where increasing the Na+ concentration in the medium stimulates the efflux pathway (418). It is important that the set point is above the resting [Ca2+]c of typical cells, since otherwise there would be an inexorable increase in mitochondrial Ca2+. Ordinarily, this mechanism is adapted to cope with peak elevations in [Ca2+]c (for review, see Ref. 412).
In mitochondria operating below the set point, matrix
[Ca2+] ([Ca2+]m) is low and
responsive to changes in [Ca2+]c. Three key
metabolic enzymes, pyruvate dehydrogenase, isocitrate dehydrogenase,
and 2-oxoglutarate dehydrogenase, are activated by increases in
[Ca2+]m, and the increased flux of the citric
acid cycle is reflected in an increased reduction state of NADH and a
slight increase in
p when [Ca2+]m responds
to an increased [Ca2+]c (211,
367). This is a means of activating the respiratory chain in
response to hormonal stimuli that lead to a physiological increase in
[Ca2+]c, allowing an increased "static
head"
p to offset the increased drop in potential as the proton
current is increased in response to increased cellular ATP demand, or
net Ca2+ accumulation itself (reviewed in Ref. 211). Thus
an increase in [Ca2+]c in synaptosomes
resulted in an increased activity of pyruvate dehydrogenase
(212), while NAD(P)H autofluorescence (which largely reflects the mitochondrial pool) was enhanced by increase in
[Ca2+]c in dissociated mouse sensory neurons
(141).
Calcium accumulation by isolated mitochondria can lower

m in one of three ways (Fig.
3). First, in the absence of phosphate, the capacity of isolated mitochondria to accumulate Ca2+ is
restricted, since the protons extruded by the respiratory chain during
Ca2+ accumulation are no longer neutralized by phosphate
uptake (632). Under these conditions, a progressive
alkalinization of the matrix occurs, which can ultimately result in
almost 2 pH units across the inner membrane and a 
m
reduced to ~100 mV (410).
|
The second means by which Ca2+ can lower

m occurs in the presence of excess phosphate (Fig.
3). Coaccumulation of phosphate with Ca2+ neutralizes
pH
and forms the osmotically inactive but rapidly dissociable calcium
phosphate complex. Under these conditions, there are transient
depressions in both the 
m and
pH components of
p during the uptake of the cation, due to the utilization of the
proton gradient by the Ca2+ plus phosphate transport, and
these can be sufficient to interrupt ATP synthesis or even to cause
reversal of the ATP synthase (484). Acetate can also be
used as a permeant anion to neutralize
pH (since acetate enters
together with a proton), but this combination causes matrix swelling
since calcium acetate is osmotically active.
The accumulation of Ca2+ in the presence of excess
phosphate should be capable of continuing indefinitely, since phosphate
neutralizes the alkalinization of the matrix (Fig. 3), as long as there
is space in the matrix for the osmotically inactive
calcium-phosphate complex. In practice, mitochondria incubated in
media approximating to the physiological cytoplasm (including adenine
nucleotides and Mg2+) can accumulate and retain in excess
of 100 mM total Ca2+ (e.g., >200 nmol Ca2+/mg
mitochondrial protein in a matrix volume of ~1 µl/mg protein; Ref.
418) with no apparent deterioration in their capacity to maintain a
high
p or to generate ATP (418, 484).
The third mechanism by which Ca2+ accumulation may lower

m (Fig. 3) is the condition of Ca2+
overload leading to mitochondrial swelling (as evidenced by a decreased
90° light scattering at 540 nm), loss of respiratory control,
collapse of 
m, and release of matrix Ca2+
caused by a permeabilization of the mitochondrial inner membrane to
sucrose and other molecules up to ~1.5 kDa (11a). This MPT is most
readily observed with isolated mitochondria incubated in the presence
of phosphate and Ca2+, but in the absence of adenine
nucleotides and Mg2+ (see Refs. 42, 44, 634 for reviews).
It is unclear what relation free as opposed to total matrix
Ca2+ has to mitochondrial dysfunction. Thus the deleterious
effects of Ca2+ increase with phosphate concentration,
whereas at the same time [Ca2+]m decreases
due to the formation of the Ca2+-phosphate complex
(632).
That the MPT is mediated by a pore in the inner membrane, rather than by membrane damage during the isolation of mitochondria, was demonstrated by Hunter and Haworth and co-workers (246, 247). They showed, by using hyperosmotic solutions of polyethylene glycol of different molecular weights, that the MPT possessed a permeability cut off for solutes at ~1,500 Da (247). Direct evidence for the existence of a pore was later obtained with electrophysiological measurements of a "mitochondrial megachannel" with properties qualitatively similar to the MPT (633). The maximum conductance of the megachannel is reported to be between 1 and 1.5 nS (633), with long-lasting closed states. The molecular identity of the pore remains elusive, but a number of components including the adenine nucleotide translocator, mitochondrial porin, and the peripheral benzodiazepine receptor are implicated in either its regulation or formation at membrane contact sites (208, 209).
The MPT is facilitated by factors that enhance oxidative stress or
deplete the matrix adenine nucleotide pool such as pyrophosphate and
atractylate (which locks the adenine nucleotide translocator in the
C-conformation in which the binding site faces the cytoplasm). Conversely, the MPT is largely prevented by including Mg2+
and adenine nucleotides in the medium, by bongkrekate (which locks the
adenine nucleotide in the matrix or M-conformation), and by cyclosporin
derivatives that interact with a mitochondrial cyclophilin which
associates with the adenine nucleotide translocator. Chelation of
extramitochondrial Ca2+ with EGTA can also reverse the MPT
(11a). However, a recent confocal study of immobilized mitochondria
(248) has shown that individual mitochondria can undergo
stochastic, cyclosporin-sensitive, large-amplitude fluctuations in

m even in the absence of Ca2+.
The Ca2+ ionophores that have been commonly used in
mitochondrial studies are ionomycin and A-23187, which function as
electroneutral Ca2+/2H+ exchangers. Their
effect in mitochondria is to create an additional Ca2+
efflux pathway in the inner membrane, depleting the matrix of Ca2+ (456, 475). In contrast to the slow
Ca2+ cycling that occurs between the uniporter and the
relatively low activity endogenous efflux pathway, the rate of
Ca2+ cycling in the presence of excess ionophore is only
limited by the activity of the Ca2+ uniporter and is hence
controlled by [Ca2+]o. In elevated
[Ca2+]o (>1-2 µM), this dissipative
cycling can have a similar effect to a protonophore, collapsing

m and inducing uncontrolled respiration (219).
B. Ca2+ Transport by In Situ Mitochondria
Calcium homeostasis, metabolism, and bioenergetics are intimately interconnected in the intact cell and must be considered as part of an integrated system (Fig. 2). Mitochondrial respiration drives both ATP synthesis and Ca2+ accumulation. Because these two processes compete for the proton circuit, they should be considered together in an analysis of the effects of cellular Ca2+ loading; thus, although Ca2+ accumulation by the mitochondria may affect ATP synthesis, alterations in ATP synthesis will in turn affect the activity of ion pumps responsible for removing Ca2+ from the cytoplasm.
The early studies with isolated mitochondria discussed above predicted that mitochondria would accumulate Ca2+ whenever [Ca2+]o rose above the set point at which uptake and efflux balanced (410). A major goal of recent studies with intact neurons has been to determine how mitochondrial Ca2+ accumulation might affect cellular Ca2+ homeostasis, particularly in response to the Ca2+ loading via voltage-activated Ca2+ channels or NMDA receptor activation. The cytoplasmic Ca2+ transients measured with fluorescent Ca2+ probes during depolarization of neurons with KCl (103, 141, 144), glutamate (102, 104, 473, 594), or trains of action potentials (109, 602) rise well above the predicted mitochondrial set point and should therefore be influenced by mitochondrial Ca2+ sequestration. Qualitative confirmation that the mitochondria have accumulated Ca2+ has been obtained by protonophore addition to a Ca2+-loaded cell. This will release any accumulated mitochondrial Ca2+ to the cytoplasm, giving a transient elevation in [Ca2+]c preceding any subsequent effects due to ATP depletion. When such experiments are performed with resting, polarized neurons, no cytoplasmic transients are observed, consistent with mitochondria being largely depleted of Ca2+ below their set point; however, protonophore addition to cells after Ca2+ loading produces the predicted spike in [Ca2+]c (73, 565, 566, 598, 602, 603).
Although the Ca2+-2H+ antiport ionophores
ionomycin or A-23187 are frequently added to cells in an attempt to
increase [Ca2+]c (e.g., Refs. 89, 303, 312,
434, 447, 525), the incorporation of the ionophore into the inner
mitochondrial membrane and resulting dissipative Ca2+
cycling can depolarize 
m with deleterious effects on
ATP levels comparable to a protonophore (7).
The kinetics of mitochondrial Ca2+ transport suggested a model in which the organelles would act as temporary stores of Ca2+ during cytoplasmic Ca2+ peaks, blunting the cytoplasmic response and releasing the Ca2+ back to the cytoplasm when [Ca2+]c recovered to below the set point (8, 412). In 1990, Thayer and Miller (565) obtained direct evidence for this by showing that brief KCl-mediated depolarization of dorsal root ganglion cells was followed by a recovery in [Ca2+]c to a plateau of 200-600 nM (549, 565). This elevated plateau was interpreted to be a consequence of the slow release from the mitochondrion of Ca2+ accumulated at the peak [Ca2+]c. A similar plateau was observed in these cells following trains of action potentials (602). Comparable plateaus have subsequently been reported for bullfrog sympathetic neurons (173) or chromaffin cells (29, 229).
The cationic fluorescent Ca2+ indicator rhod 2 can be localized within the mitochondrial matrix to monitor [Ca2+]m (268, 385, 447, 448, 570). Rhod 2 has been used to detect histamine-induced oscillations in [Ca2+]m (268) and mitochondrial Ca2+ accumulation in both glutamate-exposed striatal neurons (447, 448) and field-stimulated lizard nerve terminals (118). In the last example, a mitochondrial signal was only observed after a train of 15-20 pulses, consistent with the need to exceed the threshold imposed by the set point. A limitation, however, with rhod 2 is its relatively high affinity (dissociation constant = 0.6 µM), which means that it is saturated by >5 µM free Ca2+.
The problem inherent in studies aimed at assessing the role of mitochondrial Ca2+ transport lies in the ability to perform appropriate control experiments in which mitochondrial Ca2+ uptake is selectively inhibited. There are currently no specific, cell-permeant inhibitors of the mitochondrial Ca2+ uniporter, although the ruthenium amine complex Ru-360 is a possible candidate (363). The hexavalent glycoprotein stain ruthenium red (343, 560) is effective with isolated mitochondria at low concentrations; however, there is little evidence that it can permeate across the plasma membrane of neurons. Experiments in which ruthenium red or La3+ have been shown to antagonize the neurotoxic effects of NMDA receptor activation (e.g., Refs. 131, 150, 257) may be primarily due to inhibition of plasma membrane voltage-activated Ca2+ channels or NMDA receptors (352, 560). Penetration of the stain into the somata of cultured neurons accompanying excitotoxicity has been reported (560), but it is not clear whether the appearance of ruthenium red in the cytoplasm preceded plasma membrane permeabilization. This criticism of course does not apply to experiments in which ruthenium red is loaded via the electrode in whole cell patch-clamp experiments (e.g., Refs. 221, 438, 565).
A possible inhibitor of the mitochondrial Ca2+ efflux pathway has been investigated by a number of groups (33, 241, 529, 604, 605). 7-Chloro-3,5-dihydro-5-phenyl-1H-4,1-benzothiazepine-2-one (CGP-37157) inhibits the mitochondrial Na+/Ca2+ exchanger and would therefore be predicted to lower the mitochondrial set point and potentially to lead to massive, essentially irreversible, Ca2+ accumulation by the mitochondria. Addition of the inhibitor immediately subsequent to glutamate facilitates the restoration of basal [Ca2+]c in cultured forebrain neurons (605). Unfortunately, the inhibitor also inhibits voltage-gated Ca2+ channels, preventing its application to such studies (33). The lipophilic cation TPP+, discussed in section IIIB has been reported to inhibit the Na+-dependent mitochondrial Ca2+ efflux pathway (278, 608), and the cation has been used in a recent study (559) in an attempt to establish the role of presynaptic mitochondrial Ca2+ transport in the posttetanic potentiation of synaptic transmission. However, the extracellular concentration employed, 10 µM, would give an estimated 100 mM within the mitochondrial matrix (see Eq. 5) which would result in extensive mitochondrial swelling and depolarization, with consequent compromised ATP synthesis and Ca2+ sequestration.
In the absence of selective, permeant mitochondrial Ca2+ uniport inhibitors, an indirect approach has to be taken to inhibit mitochondrial Ca2+ transport in intact neurons. That most frequently adopted has been to depolarize the mitochondria. However, addition of a protonophore can lead to profound ATP depletion as well as causing cytoplasmic acidification and releasing glutamate from synaptic vesicles. With this in mind, it has generally been reported that the addition of a protonophore leads to an increased cytoplasmic Ca2+ elevation in response to a Ca2+ load induced by elevated KCl (73, 549, 565) or glutamate activation of NMDA receptors (292, 566). However, in such experiments, it is difficult to distinguish between an increased [Ca2+]c as a consequence of failed mitochondrial Ca2+ sequestration and one due to inhibited Ca2+ extrusion after ATP depletion. This was already recognized in 1990, when Duchen et al. (144) reported enhanced cytoplasmic Ca2+ transients in dorsal root ganglion cells exposed to a range of metabolic inhibitors, including protonophores, cyanide, and glucose removal, but observed that these effects could be a consequence of impaired Ca2+ extrusion from the cells as well as inhibited mitochondrial sequestration. Similar results have been obtained with cortical neurons (472), hippocampal neurons (598), avian cochlear neurons (392), and cerebellar granule cells (73).
In cells with active glycolysis, the ATP synthase inhibitor oligomycin can be employed to reduce the number of parameters affected by mitochondrial depolarization. Comparison of the [Ca2+]c signal evoked, for example, by elevated KCl in cells in the presence of oligomycin with those incubated with oligomycin plus a respiratory chain inhibitor allows the effect of inhibited mitochondrial Ca2+ sequestration to be observed in the absence of ATP synthase reversal (73, 74, 85, 141, 517, 519). In designing such experiments, the reversibility of inhibitor binding needs to be taken into consideration. High-affinity inhibitors such as rotenone, antimycin A, and oligomycin (116) are effectively irreversible, whereas cyanide and ionophores including carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) can be readily removed by washing.
In view of the evidence that mitochondria sequester much of the Ca2+ load imposed by KCl depolarization, it would be predicted that abolition of the mitochondrial pool would enhance a subsequent cytoplasmic Ca2+ transient. However, the results are surprising; granule cells maintaining a high ATP/ADP in the presence of rotenone/oligomycin (73) and display reduced cytoplasmic Ca2+ responses to KCl depolarization or NMDA receptor activation (73, 74, 85), whereas increased signals are obtained in cells treated with protonophore before Ca2+ loading. Although a decreased bulk cytoplasmic Ca2+ elevation when the cell's main Ca2+ sink is inactivated is counterintuitive, it is supported by the decreased total accumulation of 45Ca2+ by neurons under these conditions (74).
| |
V. REACTIVE OXYGEN SPECIES AND MITOCHONDRIA |
|---|
|
|
|---|
A. ROS Generation by Isolated Mitochondria
Oxidative stress is a common feature of many different forms of neurodegenerative disease (for review, see Ref. 38). To rationalize a large and complex field, it is helpful to first consider the mechanisms for the endogenous generation of ROS.
Although molecular oxygen is reduced to water in the terminal complex
IV by a sequential four-electron transfer, a minor proportion can
be reduced by a 1e
addition that occurs
predominantly in complex III (56, 362, 544) but also in
complex I (228, 577). The cyclic electron transfer pathway
within complex III (the Q cycle; see Ref. 416 for review) involves a
site close to the cytoplasmic face of the membrane where
UQH2 transfers a single electron to cytochrome c1 via the Rieske iron-sulfur protein,
leaving a highly reactive ubisemiquinone UQ
·. Loss of
the second electron and generation of UQ is dependent on the transfer
of the electron through two sequential cytochrome b
prosthetic groups located on opposite sides of the inner membrane (628). This transfer is therefore opposed by

m such that a high 
m enhances the
occupancy of the ubisemiquinone binding site, where a chance exists
that this second electron can be transferred to molecular oxygen,
generating the superoxide anion O2
·
(576). The inhibitor antimycin A increases
O2
· production by inhibiting reduction of the
second b cytochrome, while myxathiazol has the opposite
effect by inhibiting the initial generation of the semiquinone
(307, 576). Recently, a Q cycle-related pathway of
electron transfer has been proposed for complex I (146).
Very high membrane potentials (e.g., during succinate respiration in
state 4) are required to generate significant amounts of
O2
· (534) or
H2O2 (57). Succinate-supported
O2
· production is strongly inhibited in state 3 (57), although complex I substrates are unaffected by the
decrease in 
m and may be the main contributors to
O2
· production during state 3 respiration
(228). The nonohmic proton leak (408, 425)
may function to limit 
m and hence potentially toxic
O2
· generation (534).
Proton-motive force can also be regulated by uncoupling proteins
(UCP). In addition to the original UCP, UCP1 (220), other
isoforms have recently been identified (168). The protein
UCP2 is widely expressed and has been proposed to control ROS
generation by limiting 
m (403).
Calcium loading of isolated mitochondria in the presence of phosphate
increases the production of O2
· (14